149 related articles for article (PubMed ID: 27966721)
1. Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer.
Sun Y; Ai X; Hou J; Ye X; Liu R; Shen S; Li Z; Lu S
Mol Biosyst; 2017 Jan; 13(2):330-337. PubMed ID: 27966721
[TBL] [Abstract][Full Text] [Related]
2. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
3. Conformational stabilization of FOX-DNA complex architecture to sensitize prostate cancer chemotherapy.
Chen B; Wang H; Wu Z; Duan B; Bai P; Zhang K; Li W; Zheng J; Xing J
Amino Acids; 2017 Jul; 49(7):1247-1254. PubMed ID: 28474127
[TBL] [Abstract][Full Text] [Related]
4. Rational identification of natural organic compounds to target the intermolecular interaction between Foxm and DNA in colorectal cancer.
Dong C; Yan P; Wang J; Mu H; Wang S; Guo F
Bioorg Chem; 2017 Feb; 70():12-16. PubMed ID: 27881238
[TBL] [Abstract][Full Text] [Related]
5. Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.
Ramirez UD; Nikonova AS; Liu H; Pecherskaya A; Lawrence SH; Serebriiskii IG; Zhou Y; Robinson MK; Einarson MB; Golemis EA; Jaffe EK
BMC Cancer; 2015 May; 15():436. PubMed ID: 26016476
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of forkhead transcription factors binding to a novel palindromic DNA site.
Li J; Dai S; Chen X; Liang X; Qu L; Jiang L; Guo M; Zhou Z; Wei H; Zhang H; Chen Z; Chen L; Chen Y
Nucleic Acids Res; 2021 Apr; 49(6):3573-3583. PubMed ID: 33577686
[TBL] [Abstract][Full Text] [Related]
7. [Expression and purification of FOXO1 DNA binding domain and its DNA properties].
Ha Y; Li J; Chen Y; Chen L; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):1-7. PubMed ID: 28216490
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
Ebrahim HY; El Sayed KA
Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26978377
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology-based virtual screening of natural products from Clerodendrum species for identification of novel anti-cancer therapeutics.
Gogoi B; Gogoi D; Silla Y; Kakoti BB; Bhau BS
Mol Biosyst; 2017 Jan; 13(2):406-416. PubMed ID: 28070575
[TBL] [Abstract][Full Text] [Related]
10. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
[TBL] [Abstract][Full Text] [Related]
11. Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay.
Ou T; Hou X; Guan S; Dai J; Han W; Li R; Wang W; Qu X; Zhang M
Nat Prod Res; 2016 Jun; 30(11):1240-7. PubMed ID: 26166578
[TBL] [Abstract][Full Text] [Related]
12. Combined QSAR-based virtual screening and fluorescence binding assay to identify natural product mediators of Interferon Regulatory Factor 7 (IRF-7) in pulmonary infection.
Liu Y; Huang L; Ye H; Lv X
SAR QSAR Environ Res; 2016 Nov; 27(11):967-976. PubMed ID: 27762146
[TBL] [Abstract][Full Text] [Related]
13. Identification of Potential Inhibitors of MurD Enzyme of
Zheng X; Zheng T; Liao Y; Luo L
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770835
[No Abstract] [Full Text] [Related]
14. FOXO1 forkhead domain mutants in B-cell lymphoma lack transcriptional activity.
Sablon A; Bollaert E; Pirson C; Velghe AI; Demoulin JB
Sci Rep; 2022 Jan; 12(1):1309. PubMed ID: 35079069
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products.
Luo L; Zhong A; Wang Q; Zheng T
Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049884
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A.
Çınaroğlu SS; Timuçin E
J Mol Graph Model; 2019 Jan; 86():149-159. PubMed ID: 30366191
[TBL] [Abstract][Full Text] [Related]
17. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
[TBL] [Abstract][Full Text] [Related]
18. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation.
Raj U; Kumar H; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2115-29. PubMed ID: 26471877
[TBL] [Abstract][Full Text] [Related]
19. Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approaches.
Sasikala D; Jeyakanthan J; Srinivasan P
J Recept Signal Transduct Res; 2016 Oct; 36(5):515-30. PubMed ID: 26795501
[TBL] [Abstract][Full Text] [Related]
20. Computational Methodologies in the Exploration of Marine Natural Product Leads.
Pereira F; Aires-de-Sousa J
Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30011882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
